We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Rocket Lab Corp
RKLB
$51.2B
| $434K | ﹤0.01% |
+72,324
| New | +$332K |
|
1252
Protagonist Therapeutics
PTGX
$9.8B
| $431K | ﹤0.01% |
15,588
-449,735
| -97% | -$11.3M |
|
1253
Capri Holdings
CPRI
$1.77B
| $418K | ﹤0.01% |
+11,653
| New | +$462K |
|
1254
Jefferies Financial Group
JEF
$12.9B
| $416K | ﹤0.01% |
12,531
-83,028
| -87% | -$2.59M |
|
|
NEWR
1255
DELISTED
New Relic, Inc.
NEWR
| $415K | ﹤0.01% |
+6,339
| New | +$457K |
|
1256
Kemper
KMPR
$1.59B
| $413K | ﹤0.01% |
8,556
-20,561
| -71% | -$995K |
|
|
DENN
1257
DELISTED
Denny's
DENN
| $410K | ﹤0.01% |
33,310
-75,496
| -69% | -$857K |
|
1258
Vulcan Materials
VMC
$36B
| $409K | ﹤0.01% |
1,815
-3,183
| -64% | -$610K |
|
1259
APA Corp
APA
$14B
| $403K | ﹤0.01% |
+11,806
| New | +$412K |
|
1260
B&G Foods
BGS
$299M
| $396K | ﹤0.01% |
+28,439
| New | +$409K |
|
1261
Camden Property Trust
CPT
$11.1B
| $392K | ﹤0.01% |
3,604
-37,015
| -91% | -$3.99M |
|
1262
Datadog
DDOG
$90.6B
| $392K | ﹤0.01% |
3,986
-314,129
| -99% | -$26.3M |
|
1263
OGE Energy
OGE
$9.71B
| $390K | ﹤0.01% |
+10,861
| New | +$400K |
|
1264
GDS Holdings
GDS
$6.97B
| $387K | ﹤0.01% |
35,251
+22,784
| +183% | +$303K |
|
|
WIRE
1265
DELISTED
Encore Wire Corp
WIRE
| $384K | ﹤0.01% |
2,066
-12,571
| -86% | -$2.13M |
|
1266
Roblox
RBLX
$27.1B
| $382K | ﹤0.01% |
9,469
-1,756,140
| -99% | -$70.5M |
|
1267
Procept Biorobotics
PRCT
$1.26B
| $380K | ﹤0.01% |
10,750
-99,136
| -90% | -$3.28M |
|
1268
Kyndryl
KD
$3.04B
| $379K | ﹤0.01% |
28,539
-129,535
| -82% | -$1.75M |
|
1269
Relmada Therapeutics
RLMD
$507M
| $374K | ﹤0.01% |
152,235
-105,688
| -41% | -$292K |
|
1270
Expro Ltd
XPRO
$2.1B
| $360K | ﹤0.01% |
20,323
-35,380
| -64% | -$638K |
|
1271
Commault Systems
CVLT
$6.26B
| $359K | ﹤0.01% |
+4,948
| New | +$322K |
|
1272
Savers
SVV
$1.67B
| $356K | ﹤0.01% |
+15,000
| New | +$350K |
|
1273
Charter Communications
CHTR
$18.7B
| $344K | ﹤0.01% |
+936
| New | +$319K |
|
1274
Bread Financial
BFH
$4.51B
| $341K | ﹤0.01% |
+10,870
| New | +$312K |
|
1275
Insmed
INSM
$27.6B
| $339K | ﹤0.01% |
+16,044
| New | +$304K |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.